The coming end of the drug rep era
American Medical News reports Doctors increasingly close doors to drug reps, while pharma cuts ranks and Mass. bans drug- and device-makers’ gifts to doctors and forces pay disclosures. From the latter article:
The new regulations implement a state law enacted last year and bar industry gifts such as pens, notepads and food in physician offices. The restrictions are meant to reduce health care costs…
I’m sure we will eventually see the cost of prescription drugs come down. I just think it will be because the pharmaceutical industry — or what is eventually left of it — will stop spending hundreds of millions of dollars of R & D money per new drug when they know they won’t be able to market the drug and recoup their investment. But it’s nice to know that our national nightmare of 99 cent drug rep pens is finally coming to an end.